Standard InChI: InChI=1S/C21H22F3NO4/c1-3-15(20(27)28)10-14-6-9-18(29-2)17(11-14)19(26)25-12-13-4-7-16(8-5-13)21(22,23)24/h4-9,11,15H,3,10,12H2,1-2H3,(H,25,26)(H,27,28)/t15-/m0/s1
1.Miyachi H, Uchiki H.. (2003) Analysis of the critical structural determinant(s) of species-selective peroxisome proliferator-activated receptor alpha (PPAR alpha)-activation by phenylpropanoic acid-type PPAR alpha agonists., 13 (19):[PMID:12951082][10.1016/s0960-894x(03)00715-7]
2.Miyachi H, Nomura M, Tanase T, Suzuki M, Murakami K, Awano K.. (2002) Enantio-dependent binding and transactivation of optically active phenylpropanoic acid derivatives at human peroxisome proliferator-activated receptor alpha., 12 (3):[PMID:11814790][10.1016/s0960-894x(01)00732-6]
3.Nomura M, Tanase T, Ide T, Tsunoda M, Suzuki M, Uchiki H, Murakami K, Miyachi H.. (2003) Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators., 46 (17):[PMID:12904063][10.1021/jm0205144]
4.Kurosumi M, Nishio Y, Osawa S, Kobayashi H, Iwatsubo T, Tomita T, Miyachi H.. (2010) Novel Notch-sparing gamma-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library., 20 (17):[PMID:20650635][10.1016/j.bmcl.2010.06.131]
5.Pirat C, Farce A, Lebègue N, Renault N, Furman C, Millet R, Yous S, Speca S, Berthelot P, Desreumaux P, Chavatte P.. (2012) Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators., 55 (9):[PMID:22260081][10.1021/jm101360s]